Breast Lesion Localization Methods - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB503243953

Publication Date:

March 15, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products.
The global market for Breast Lesion Localization Methods was estimated to be worth US$ 334.6 million in 2023 and is forecast to a readjusted size of US$ 450.9 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
The main market for breast lesion targeting methods is North America, which accounts for about 50% of the market, followed by Europe, which accounts for more than 25%.
Major companies include C.R. Bard, Cook Medical, Somatex Medical, Argon Medical Devices, Theragenics, etc., with the top three accounting for more than 80% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Breast Lesion Localization Methods, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Breast Lesion Localization Methods by region & country, by Type, and by End User.
The Breast Lesion Localization Methods market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Lesion Localization Methods.
Market Segmentation
By Company
C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB
Segment by Type:
Wire Localization Biopsy
Radioisotope Localization
Magnetic Tracer
Other
Segment by End User
Women
Men
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Breast Lesion Localization Methods manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Breast Lesion Localization Methods in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Breast Lesion Localization Methods in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Breast Lesion Localization Methods Product Introduction
1.2 Global Breast Lesion Localization Methods Market Size Forecast
1.3 Breast Lesion Localization Methods Market Trends & Drivers
1.3.1 Breast Lesion Localization Methods Industry Trends
1.3.2 Breast Lesion Localization Methods Market Drivers & Opportunity
1.3.3 Breast Lesion Localization Methods Market Challenges
1.3.4 Breast Lesion Localization Methods Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Breast Lesion Localization Methods Players Revenue Ranking (2023)
2.2 Global Breast Lesion Localization Methods Revenue by Company (2019-2024)
2.3 Key Companies Breast Lesion Localization Methods Manufacturing Base Distribution and Headquarters
2.4 Key Companies Breast Lesion Localization Methods Product Offered
2.5 Key Companies Time to Begin Mass Production of Breast Lesion Localization Methods
2.6 Breast Lesion Localization Methods Market Competitive Analysis
2.6.1 Breast Lesion Localization Methods Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Breast Lesion Localization Methods Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Lesion Localization Methods as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wire Localization Biopsy
3.1.2 Radioisotope Localization
3.1.3 Magnetic Tracer
3.1.4 Other
3.2 Global Breast Lesion Localization Methods Sales Value by Type
3.2.1 Global Breast Lesion Localization Methods Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Breast Lesion Localization Methods Sales Value, by Type (2019-2030)
3.2.3 Global Breast Lesion Localization Methods Sales Value, by Type (%) (2019-2030)
4 Segmentation by End User
4.1 Introduction by End User
4.1.1 Women
4.1.2 Men
4.2 Global Breast Lesion Localization Methods Sales Value by End User
4.2.1 Global Breast Lesion Localization Methods Sales Value by End User (2019 VS 2023 VS 2030)
4.2.2 Global Breast Lesion Localization Methods Sales Value, by End User (2019-2030)
4.2.3 Global Breast Lesion Localization Methods Sales Value, by End User (%) (2019-2030)
5 Segmentation by Region
5.1 Global Breast Lesion Localization Methods Sales Value by Region
5.1.1 Global Breast Lesion Localization Methods Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Breast Lesion Localization Methods Sales Value by Region (2019-2024)
5.1.3 Global Breast Lesion Localization Methods Sales Value by Region (2025-2030)
5.1.4 Global Breast Lesion Localization Methods Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Breast Lesion Localization Methods Sales Value, 2019-2030
5.2.2 North America Breast Lesion Localization Methods Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Breast Lesion Localization Methods Sales Value, 2019-2030
5.3.2 Europe Breast Lesion Localization Methods Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Breast Lesion Localization Methods Sales Value, 2019-2030
5.4.2 Asia Pacific Breast Lesion Localization Methods Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Breast Lesion Localization Methods Sales Value, 2019-2030
5.5.2 South America Breast Lesion Localization Methods Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Breast Lesion Localization Methods Sales Value, 2019-2030
5.6.2 Middle East & Africa Breast Lesion Localization Methods Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Breast Lesion Localization Methods Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Breast Lesion Localization Methods Sales Value
6.3 United States
6.3.1 United States Breast Lesion Localization Methods Sales Value, 2019-2030
6.3.2 United States Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
6.4 Europe
6.4.1 Europe Breast Lesion Localization Methods Sales Value, 2019-2030
6.4.2 Europe Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
6.5 China
6.5.1 China Breast Lesion Localization Methods Sales Value, 2019-2030
6.5.2 China Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.5.3 China Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
6.6 Japan
6.6.1 Japan Breast Lesion Localization Methods Sales Value, 2019-2030
6.6.2 Japan Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Breast Lesion Localization Methods Sales Value, 2019-2030
6.7.2 South Korea Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Breast Lesion Localization Methods Sales Value, 2019-2030
6.8.2 Southeast Asia Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
6.9 India
6.9.1 India Breast Lesion Localization Methods Sales Value, 2019-2030
6.9.2 India Breast Lesion Localization Methods Sales Value by Type (%), 2023 VS 2030
6.9.3 India Breast Lesion Localization Methods Sales Value by End User, 2023 VS 2030
7 Company Profiles
7.1 C.R. BARD
7.1.1 C.R. BARD Profile
7.1.2 C.R. BARD Main Business
7.1.3 C.R. BARD Breast Lesion Localization Methods Products, Services and Solutions
7.1.4 C.R. BARD Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.1.5 C.R. BARD Recent Developments
7.2 Cook Medical
7.2.1 Cook Medical Profile
7.2.2 Cook Medical Main Business
7.2.3 Cook Medical Breast Lesion Localization Methods Products, Services and Solutions
7.2.4 Cook Medical Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.2.5 Cook Medical Recent Developments
7.3 Cianna Medical
7.3.1 Cianna Medical Profile
7.3.2 Cianna Medical Main Business
7.3.3 Cianna Medical Breast Lesion Localization Methods Products, Services and Solutions
7.3.4 Cianna Medical Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.3.5 Eckert & Ziegler Recent Developments
7.4 Eckert & Ziegler
7.4.1 Eckert & Ziegler Profile
7.4.2 Eckert & Ziegler Main Business
7.4.3 Eckert & Ziegler Breast Lesion Localization Methods Products, Services and Solutions
7.4.4 Eckert & Ziegler Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.4.5 Eckert & Ziegler Recent Developments
7.5 Theragenics
7.5.1 Theragenics Profile
7.5.2 Theragenics Main Business
7.5.3 Theragenics Breast Lesion Localization Methods Products, Services and Solutions
7.5.4 Theragenics Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.5.5 Theragenics Recent Developments
7.6 Argon Medical Devices
7.6.1 Argon Medical Devices Profile
7.6.2 Argon Medical Devices Main Business
7.6.3 Argon Medical Devices Breast Lesion Localization Methods Products, Services and Solutions
7.6.4 Argon Medical Devices Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.6.5 Argon Medical Devices Recent Developments
7.7 SOMATEX Medical
7.7.1 SOMATEX Medical Profile
7.7.2 SOMATEX Medical Main Business
7.7.3 SOMATEX Medical Breast Lesion Localization Methods Products, Services and Solutions
7.7.4 SOMATEX Medical Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.7.5 SOMATEX Medical Recent Developments
7.8 IsoAid
7.8.1 IsoAid Profile
7.8.2 IsoAid Main Business
7.8.3 IsoAid Breast Lesion Localization Methods Products, Services and Solutions
7.8.4 IsoAid Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.8.5 IsoAid Recent Developments
7.9 Endomag
7.9.1 Endomag Profile
7.9.2 Endomag Main Business
7.9.3 Endomag Breast Lesion Localization Methods Products, Services and Solutions
7.9.4 Endomag Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.9.5 Endomag Recent Developments
7.10 Ranfac
7.10.1 Ranfac Profile
7.10.2 Ranfac Main Business
7.10.3 Ranfac Breast Lesion Localization Methods Products, Services and Solutions
7.10.4 Ranfac Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.10.5 Ranfac Recent Developments
7.11 STERYLAB
7.11.1 STERYLAB Profile
7.11.2 STERYLAB Main Business
7.11.3 STERYLAB Breast Lesion Localization Methods Products, Services and Solutions
7.11.4 STERYLAB Breast Lesion Localization Methods Revenue (US$ Million) & (2019-2024)
7.11.5 STERYLAB Recent Developments
8 Industry Chain Analysis
8.1 Breast Lesion Localization Methods Industrial Chain
8.2 Breast Lesion Localization Methods Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Breast Lesion Localization Methods Sales Model
8.5.2 Sales Channel
8.5.3 Breast Lesion Localization Methods Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂